Welcome to our dedicated page for EUDA Health Holdings news (Ticker: EUDA), a resource for investors and traders seeking the latest updates and insights on EUDA Health Holdings stock.
EUDA Health Holdings Limited (NASDAQ: EUDA) is a Singapore-based non-invasive healthcare provider in Asia with a focus on Singapore, Malaysia and China. Company news highlights its strategy in preventive health, longevity-focused care, regenerative medicine and wellness consumer products, alongside a Singapore-based property management business.
News updates for EUDA often cover developments in its longevity and stem cell platforms, such as agreements with Shenzhen Inno Immune Co., Ltd., the launch of a nationwide stem cell extraction, cryostorage and clinical delivery platform in China, and the establishment of a longevity clinic in Shenzhen. Releases also describe EUDA’s partnerships with institutions like Wuhan Kaien Hospital and CK Health Plus’ expansion into India through SafeRock India.
Investors and observers can follow announcements about EUDA Helixé 2.0, a premium vitality and longevity supplement with upgraded formulation and delivery technology, as well as disclosures on the integration of the QB utility token into EUDA’s digital health and rewards platform. These items illustrate how the company combines wellness products, regenerative medicine programs and digital assets within one ecosystem.
EUDA’s news flow also includes capital markets activities and governance updates, such as securities purchase agreements, warrant amendments, convertible note arrangements and changes to its board of directors, as reported in press releases and related Form 6-K filings. The EUDA news page on Stock Titan aggregates these developments so readers can review corporate actions, strategic partnerships, product launches and financing events linked to EUDA’s non-invasive healthcare and longevity strategy.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
EUDA Health Holdings Limited (NASDAQ: EUDA, EUDAW), a Singapore-based health technology company, announced it received a delinquency notification from Nasdaq on April 5, 2023, due to its failure to file the Annual Report on Form 10-K for the fiscal year ending December 31, 2022. The company has 60 days to submit a compliance plan. If accepted, it could receive up to 180 days to file the report. Management is working to complete the necessary information but needs additional time for final audits. The delinquency notice does not immediately impact the trading of EUDA's common stock, which remains listed on Nasdaq.